Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.71 |
| ▸ | RAB9A | P51151 | 8/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.48 |
| ▸ | SELL | P14151 | 1/20 | 0.43 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
| ▸ | SELE | P16581 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.41 |
| ▸ | HPGD | P15428 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | IGF2BP2 | Q9Y6M1 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL110113 | 0.86 | NPC1 (0.71) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL7703339 | 0.86 | NPC1 (0.71) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL29489567 | 0.86 | NPC1 (0.71) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL105385 | 0.83 | NPC1 (0.68) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL9408736 | 0.83 | NPC1 (0.68) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL10598824 | 0.83 | NPC1 (1.00) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL18375849 | 0.83 | NPC1 (0.68) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL258759 | 0.82 | NPC1 (0.66) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL31267541 | 0.82 | NPC1 (0.66) | NPC1RAB9ALMNAPOLBALDH1A1 | |
| SCHEMBL20365734 | 0.82 | NPC1 (0.66) | NPC1RAB9ALMNAPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11078419-B2 | Substituted benzotriazole phenolate salts and antioxidant compositions formed therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-08-03 | — | — | US | disclosed |
| US-11053373-B2 | Polymeric matrices with ionic additives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-07-06 | — | — | US | disclosed |
| US-10724171-B2 | Electret webs with charge-enhancing additives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-07-28 | — | — | US | disclosed |
| US-20200172809-A1 | SUBSTITUTED BENZOTRIAZOLE PHENOLATE SALTS AND ANTIOXIDANT COMPOSITIONS FORMED THEREFROM | 3M INNOVATIVE PROPERTIES CO (US) | 2020-06-04 | — | — | US | disclosed |
| US-10669481-B2 | Substituted benzotriazole phenolate salts and antioxidant compositions formed therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-06-02 | — | — | US | disclosed |
| US-20190003112-A1 | ELECTRET WEBS WITH CHARGE-ENHANCING ADDITIVES | 3M INNOVATIVE PROPERTIES COMPANY | 2019-01-03 | — | — | US | disclosed |
| US-20180195000-A1 | SUBSTITUTED BENZOTRIAZOLE PHENOLATE SALTS AND ANTIOXIDANT COMPOSITIONS FORMED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2018-07-12 | — | — | US | disclosed |
| US-7892443-B2 | Method of manufacturing member with concave portions, member with concave portions, lens substrate, transmission type screen and rear projection | SEIKO EPSON CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-7349159-B2 | Mold for manufacturing a microlens substrate, a method of manufacturing microlens substrate, a microlens substrate, a transmission screen, and a rear projection | SEIKO EPSON CORPORATION (JP) | 2008-03-25 | — | — | US | disclosed |
| US-7265909-B2 | Lens substrate, a transmission screen and a rear projection device | SEIKO EPSON CORPORATION (JP) | 2007-09-04 | — | — | US | disclosed |
| US-20070166849-A1 | Method of manufacturing member with concave portions, member with concave portions, lens substrate, transmission type screen and rear projection | SEIKO EPSON CORPORATION | 2007-07-19 | — | — | US | disclosed |
| US-20060087741-A1 | Mold for manufacturing a microlens substrate, a method of manufacturing microlens substrate, a microlens substrate, a transmission screen, and a rear projection | SEIKO EPSON CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-20060087025-A1 | Method of manufacturing a substrate with concave portions, a substrate with concave portions, a microlens substrate, a transmission screen, and a rear projection | SEIKO EPSON CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-20060087742-A1 | Method of manufacturing a microlens substrate, a substrate with concave portions, a microlens substrate, a transmission screen, and a rear projection | SEIKO EPSON CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-20060082902-A1 | Lens substrate, a method of manufacturing a lens substrate, a transmission screen and a rear projection | SEIKO EPSON CORPORATION | 2006-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172809-A1 | SUBSTITUTED BENZOTRIAZOLE PHENOLATE SALTS AND ANTIOXIDANT COMPOSITIONS FORMED THEREFROM | COMT, OGFOD1, TYR | NPC1 4227/4885RAB9A 4875/4885LMNA 3383/4885 |
| US-10669481-B2 | Substituted benzotriazole phenolate salts and antioxidant compositions formed therefrom | COMT, OGFOD1, TYR | NPC1 4227/4885RAB9A 4875/4885LMNA 3383/4885 |
| US-11078419-B2 | Substituted benzotriazole phenolate salts and antioxidant compositions formed therefrom | COMT, OGFOD1, TYR | NPC1 4227/4885RAB9A 4875/4885LMNA 3383/4885 |
| US-20180195000-A1 | SUBSTITUTED BENZOTRIAZOLE PHENOLATE SALTS AND ANTIOXIDANT COMPOSITIONS FORMED THEREFROM | COMT, OGFOD1, TYR | NPC1 4227/4885RAB9A 4875/4885LMNA 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.